Back to Top
Roledumab Biosimilar - Research Grade
$710.00 - $6,900.00
Roledumab Biosimilar - Research Grade
Endotoxin
≤ 1.0 EU/mg as determined by the LAL method
Purity
>90% by SDS-PAGE
Species Reactivity
Human
Target
RHDï؟½
Concentration
5mg/ml
Isotype
IgG1 - kappa
Host
CHO Cells
Sequence
https://www.imgt.org/mAb-DB/
Buffer
ICH3002
Uniprot
Q02161
Shipping Conditions
Blue ice
Background
The Rhesus D (RhD) antigen is a clinically important red-cell surface protein and the principal driver of alloimmunization in hemolytic disease research. Offered here is a non-therapeutic, unconjugated analog of roledumab, an anti-RhD recombinant monoclonal antibody supplied for research use only. The reagent is produced to demanding in vivo standards with low endotoxin and is available in scalable milligram to gram quantities for laboratories running high-throughput or bulk workflows. Typical applications include functional binding assays, erythrocyte-targeting studies, and controlled in vivo models exploring antibody clearance and effector mechanisms. Its scalable supply and batch consistency suit programs that require uniform reagent across many studies.
Purification Method
This monoclonal antibody was purified using Protein A
Formulation
Sterile, preservative-free, solution in PBS. BSA and Azide free.
Storage
This biosimilar is stable when stored at 2-8°C. For longer term storage (> 3 months) it is recommended to store this antibody at -20°C or -70°C.
Applications
Functional Assays
Application Notes
This biosimilar is for research use only (RUO): it is not for diagnostic or therapeutic procedures and cannot be purchased by patients.
Use
Products are for research use only. Not for use in diagnostic or therapeutic procedures.
Delivery Time
3-4 weeks
Write Your Own Review











